×
0 -0.0823529411764705 -0.152941176470588 -0.117647058823529 -0.158823529411765 -0.323529411764706 -0.370588235294118 -0.479411764705882
Stockreport

Gemphire Therapeutics stock plunges after trial halted due to 'unanticipated problems' [MarketWatch]

GEMPHIRE THERAPEUTICS INC COMMON (GEMP)  More Company Research Source: MarketWatch
Last gemphire therapeutics inc common earnings: 8/13 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.gemphire.com
PDF Gemphire Therapeutics stock plunges after trial halted due to 'unanticipated problems' Shares of Gemphire Therapeutics Inc. GEMP, -2.39% plunged 17% toward a record low Friday after the biopharmaceutical company said a phase 2a trial of its treatment for non-alcoholic fatty liver disease in pediatric patients will be terminated, citing "unanticipated problems." The company said the data and safety monitoring board at Emory University overseeing the trial recommended the termination. Gemphire said data on the first three patients undergoing 12 weeks of treatment all experienced an increase in liver fat content, which was deemed an unexpected problem. "We remain confident that gemcabene has the potential to be an effective therapy for a host of cardiometabolic patients and we intend to continue to develop gemcabene to address multiple indications," said Chief Executive Steven Gullans. The stock has plunged 59% year to date through Thursday, while the iShares Nasdaq Biotechnology ETF [Read more]

IMPACT SNAPSHOT EVENT TIME: GEMP
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
GEMP alerts

from News Quantified
Opt-in for
GEMP alerts

from News Quantified